Seres Therapeutics Inc. (MCRB)

NASDAQ: MCRB · Real-Time Price · USD

9.65

0.16 (1.63%)

At close: May 02, 2025, 3:59 PM

9.60

-0.52%

After-hours: May 02, 2025, 05:20 PM EDT

Seres Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	136K	-113.72M	-250.16M	-65.58M	-89.13M	-70.28M	-98.94M	-89.38M	-91.58M
Depreciation & Amortization	5.47M	6.24M	6.63M	5.95M	6.58M	7.6M	7.86M	7.26M	4.21M
Stock-Based Compensation	20.97M	34.1M	25.48M	20.22M	8.82M	8.34M	16.64M	17.36M	16.86M
Other Working Capital	-26.71M	-9.08M	-20.59M	-4.36M	-11.56M	-17.52M	12.15M	-9.7M	111.24M
Other Non-Cash Items	-109.67M	15M	7.62M	2.04M	3.31M	2.34M	-214K	-213K	-386K
Deferred Income Tax	n/a	n/a	n/a	2.53M	n/a	103K	n/a	n/a	n/a
Change in Working Capital	-65.51M	-58.98M	-18.39M	41.53M	-23.2M	-24.63M	11.8M	-10.55M	114.82M
Operating Cash Flow	-148.61M	-117.35M	-228.82M	6.69M	-93.61M	-76.52M	-62.85M	-75.52M	43.92M
Capital Expenditures	-380K	-7.97M	-9.82M	-9.57M	-591K	-1M	-1.94M	-4.68M	-21.49M
Cash Acquisitions	n/a	n/a	-92.25M	-73.65M	19.9M	29.52M	n/a	n/a	n/a
Purchase of Investments	n/a	-4.43M	-48.22M	-95.97M	-218.28M	-46.42M	-21.83M	-96.53M	-290.59M
Sales Maturities Of Investments	n/a	22.98M	140.47M	169.63M	59.98M	16.9M	136.09M	158.31M	246.49M
Other Investing Acitivies	142.67M	n/a	92.25M	73.65M	-19.9M	-29.52M	114.25M	-113K	139K
Investing Cash Flow	142.29M	10.58M	82.43M	64.09M	-158.89M	-30.52M	112.32M	56.99M	-65.45M
Debt Repayment	-127.91M	50.52M	25.7M	-948K	19.9M	25M	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	-197K	-33K	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	14M	3.03M	2.73M	2.13M	14.88M	16K	404K	116K	2.14M
Financial Cash Flow	-90.37M	71.7M	129.6M	1.18M	303.42M	86.23M	268K	83K	2.14M
Net Cash Flow	-96.69M	-35.06M	-16.79M	71.95M	50.92M	-20.81M	49.73M	-18.45M	-19.39M
Free Cash Flow	-148.99M	-125.33M	-238.64M	-2.88M	-94.2M	-77.52M	-64.79M	-80.2M	22.43M